ERBB2 and breast cancer: In GOBO analysis, the expression of GATA3 in luminal-like was significantly higher than basal-A or basal-B subtypes of breast cancer, and the hormone receptor (HR) sensitive subtype also expressed higher level of GATA3 than TN (triple-negative) and Her-2 clinical subtypes (Figure 4D and 4E).